Treatment of hepatitis b infection with thymosin alpha 1 in...

Details Treatment of hepatitis b infection with thymosin alpha 1 in... Treatment of hepatitis b infection with thymosin alpha 1 in...

A - Human Necessities

61

K

A61K 38/22 (2006.01) A61K 31/52 (2006.01) A61K 31/7068 (2006.01) A61P 31/20 (2006.01)

Patent

CA 2345462

Treatment of hepatitis B virus (HBV) infection in a patient by administering to the patient a drug regimen including an antiviral-effective amount of thymosin alpha 1 (T.alpha.1), an antiviral-effective amount of lamivudine, and optionally an antiviral-effective amount of famciclovir.

Ce traitement d'un patient contre l'infection au virus de l'hépatite B (HBV) consiste à administrer à celui-ci un traitement médicamenteux contenant une dose antivirale efficace de thymosine alpha 1 (T alpha 1), une dose antivirale efficace de lamivudine, et éventuellement une dose antivirale efficace de famciclovir.

Affiliated with

Also associated with

Rating

Treatment of hepatitis b infection with thymosin alpha 1 in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of hepatitis b infection with thymosin alpha 1 in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of hepatitis b infection with thymosin alpha 1 in... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1856706